IPH4102/Lacutamab Alone or in Combination With Chemotherapy in Patients With Advanced T Cell Lymphoma

Clinical trial NCT03902184 · COMPLETED

Trial details

NCT number: NCT03902184
Sponsor: Innate Pharma
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma, T-Cell Lymphoma, T-Cell, Cutaneous Mycosis Fungoides/Sezary Syndrome

Start date: 2019-05-22
Primary completion: 2026-01-08
Enrollment: 170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.